To clarify the correlation between the expression of WEE2-AS1 and the clinical, pathological, and molecular characteristics of patients with glioma, we analyzed the relationship between the WEE2-AS1 expression and the WHO grade, histological type, IDH status, 1p/19q codeletion status, and EGFR status of glioma, by using the data of TCGA (LGG-GBM). This evidence concerns the gene EGFR and central nervous system cancer.